NSCLC Stage II Clinical Trials
2 recruiting trials for NSCLC Stage II. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07410975
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage...
This study aims to evaluate the major pathologic response (MPR) rate of neoadjuvant therapy with sintilimab (PD-1 inhibitor) + IBI310 (anti-CTLA-4 antibody) + chemotherapy, and to...
Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 541 location
RECRUITINGPhase 2NCT07323732
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung...
The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people with non-small cell...
Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 257 locations